YB-1 Oncoprotein Controls PI3K/Akt Pathway by Reducing Pten Protein Level
Abstract
:1. Introduction
2. Materials and Methods
2.1. Plasmids and Reagents
2.2. Cell Cultures
2.3. Immunoblotting Analysis
2.4. Antibodies
2.5. Transfections and RNA Interference
2.6. Co-Immunoprecipitation
2.7. Quantitative Real Time-PCR
2.8. Statistical Analysis
3. Results
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Lindquist, J.A.; Mertens, P.R. Cold shock proteins: From cellular mechanisms to pathophysiology and disease. Cell Commun. Signal. 2018, 16, 11–14. [Google Scholar] [CrossRef] [Green Version]
- Metha, S.; McKinney, C.; Algie, M.; Verma, C.S.; Kannan, S.; Harfoot, R.; Bartolec, T.K.; Bhatia, P.; Fisher, A.J.; Gould, M.L.; et al. Dephosphorylation of yb-1 is required for nuclear localisation during G2 phase of the cell cycle. Cancers 2020, 12, 2–315. [Google Scholar]
- Evdokimova, V.; Ruzanov, P.; Anglesio, M.S.; Sorokin, A.S.; Ovchinnikov, L.P.; Buckley, J.; Triche, T.J.; Sonenberg, N.; Sorensen, P.H.B. Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species. Mol. Cell. Biol. 2006, 26, 277–292. [Google Scholar] [CrossRef] [Green Version]
- Fujii, T.; Yokoyama, G.; Takahashi, H.; Namoto, R.; Nakagawa, S.; Toh, U.; Kage, M.; Shirouzu, K.; Kuwano, M. Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancer. Breast Cancer 2008, 15, 73–78. [Google Scholar] [CrossRef] [PubMed]
- Kuwano, M.; Oda, Y.; Izumi, H.; Yang, S.J.; Uchiumi, T.; Iwamoto, Y.; Toi, M.; Fujii, T.; Yamana, H.; Kinoshita, H.; et al. The role of nuclear Y-box binding protein 1 as a global marker in drug resistance. Mol. Cancer Ther. 2004, 3, 1485–1492. [Google Scholar] [PubMed]
- Kashihara, M.; Azuma, K.; Kawahara, A.; Basaki, Y.; Hattori, S.; Yanagawa, T.; Terazaki, Y.; Takamori, S.; Shirouzu, K.; Aizawa, H.; et al. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer. J. Thorac. Oncol. 2009, 4, 1066–1074. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hohlfeld, R.; Brandt, S.; Bernhardt, A.; Gorny, X.; Schindele, D.; Jandrig, B.; Schostak, M.; Isermann, B.; Lindquist, J.A.; Mertens, P.R. Crosstalk between Akt signaling and cold shock proteins in mediating invasive cell phenotypes. Oncotarget 2018, 9, 19039. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cohen, S.B.; Ma, W.; Valova, V.A.; Algie, M.; Harfoot, R.; Woolley, A.G.; Robinson, P.J.; Braithwaite, A.W. Genotoxic stress-induced nuclear localization of oncoprotein YB-1 in the absence of proteolytic processing. Oncogene 2010, 29, 403–410. [Google Scholar] [CrossRef] [Green Version]
- Eliseeva, I.A.; Kim, E.R.; Guryanov, S.G.; Ovchinnikov, L.P.; Lyabin, D.N. Y-box-binding protein 1 (YB-1) and its functions. Biochemistry 2011, 76, 1402–1433. [Google Scholar] [CrossRef]
- Lettau, K.; Zips, D.; Toulany, M. Simultaneous targeting of rsk and akt efficiently inhibits yb-1-mediated repair of ionizing radiation-induced DNA double-strand breaks in breast cancer cells. Int. J. Radiat. Oncol. Biol. Phys. 2021, 109, 567–580. [Google Scholar] [CrossRef]
- Kretov, D.A.; Mordovkina, D.A.; Eliseeva, I.A.; Lyabin, D.N.; Polyakov, D.N.; Joshi, V.; Desforges, B.; Hamon, L.; Lavrik, O.I.; Pastré, D.; et al. Inhibition of transcription induces phosphorylation of YB-1 at Ser102 and its accumulation in the nucleus. Cells 2020, 9, 104. [Google Scholar] [CrossRef] [Green Version]
- Kuwano, M.; Shibata, T.; Watari, K.; Ono, M. Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer. Cancer Sci. 2019, 110, 1536–1543. [Google Scholar] [CrossRef] [PubMed]
- Maehama, T.; Dixon, J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate. J. Biol. Chem. 1998, 273, 13375–13378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Richman, S. Deficient mismatch repair: Read all about it. Int. J. Oncol. 2015, 47, 1189–1202. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Radu, A.; Neubauer, V.; Akagi, T.; Hanafusa, H.; Georgescu, M.M. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol. Cell. Biol. 2003, 23, 6139–6149. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ming, M.; He, Y.Y. PTEN in DNA damage repair. Cancer Lett. 2012, 319, 125–129. [Google Scholar] [CrossRef] [Green Version]
- Carbognin, L.; Miglietta, F.; Paris, I.; Dieci, M.V. Prognostic and predictive implications of PTEN in breast cancer: Unfulfilled promises but intriguing perspectives. Cancers 2019, 11, 1401. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Milella, M.; Falcone, I.; Conciatori, F.; Cesta Incani, U.; Del Curatolo, A.; Inzerilli, N.; Nuzzo, C.M.; Vaccaro, V.; Vari, S.; Cognetti, F.; et al. PTEN: Multiple functions in human malignant tumors. Front. Oncol. 2015, 5, 24. [Google Scholar] [CrossRef] [Green Version]
- Lee, Y.R.; Chen, M.; Pandolfi, P.P. The functions and regulation of the PTEN tumour suppressor: New modes and prospects. Nat. Rev. Mol. Cell Biol. 2018, 19, 547–562. [Google Scholar] [CrossRef]
- Heumann, A.; Kaya, Ö.; Burdelski, C.; Hube-Magg, C.; Kluth, M.; Lang, D.S.; Simon, R.; Beyer, B.; Thederan, I.; Sauter, G.; et al. Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer. Sci. Rep. 2017, 17, 2056. [Google Scholar] [CrossRef] [Green Version]
- Guarino, A.M.; Troiano, A.; Pizzo, E.; Bosso, A.; Vivo, M.; Pinto, G.; Amoresano, A.; Pollice, A.; La Mantia, G.; Calabrò, V. Oxidative stress causes enhanced secretion of YB-1 protein that restrains proliferation of receiving cells. Genes 2018, 9, 513. [Google Scholar] [CrossRef] [Green Version]
- Alimonti, A.; Carracedo, A.; Clohessy, J.G.; Trotman, L.C.; Nardella, C.; Egia, A.; Salmena, L.; Sampieri, K.; Haveman, W.J.; Brogi, E.; et al. Subtle variations in Pten dose determine cancer susceptibility. Nat. Genet. 2010, 42, 454–458. [Google Scholar] [CrossRef]
- Rich, J.N. Cancer stem cells in radiation resistance. Cancer Res. 2007, 67, 8980–8984. [Google Scholar] [CrossRef] [Green Version]
- Leslie, N.R.; Foti, M. Non-genomic loss of PTEN function in cancer: Not in my genes. Trends Pharmacol. Sci. 2011, 32, 131–140. [Google Scholar] [CrossRef]
- Mouw, J.K.; Yui, Y.; Damiano, L.; Bainer, R.O.; Lakins, J.N.; Acerbi, I.; Ou, G.; Wijekoon, A.C.; Levental, K.R.; Gilbert, P.M.; et al. Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. Nat. Med. 2014, 20, 360–367. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Blenkiron, C.; Hurley, D.G.; Fitzgerald, S.; Print, C.G.; Lasham, A. Links between the oncoprotein YB-1 and small non-coding RNAs in breast cancer. PLoS ONE 2013, 8, e80171. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Delicato, A.; Montuori, E.; Angrisano, T.; Pollice, A.; Calabrò, V. YB-1 Oncoprotein Controls PI3K/Akt Pathway by Reducing Pten Protein Level. Genes 2021, 12, 1551. https://doi.org/10.3390/genes12101551
Delicato A, Montuori E, Angrisano T, Pollice A, Calabrò V. YB-1 Oncoprotein Controls PI3K/Akt Pathway by Reducing Pten Protein Level. Genes. 2021; 12(10):1551. https://doi.org/10.3390/genes12101551
Chicago/Turabian StyleDelicato, Antonella, Eleonora Montuori, Tiziana Angrisano, Alessandra Pollice, and Viola Calabrò. 2021. "YB-1 Oncoprotein Controls PI3K/Akt Pathway by Reducing Pten Protein Level" Genes 12, no. 10: 1551. https://doi.org/10.3390/genes12101551
APA StyleDelicato, A., Montuori, E., Angrisano, T., Pollice, A., & Calabrò, V. (2021). YB-1 Oncoprotein Controls PI3K/Akt Pathway by Reducing Pten Protein Level. Genes, 12(10), 1551. https://doi.org/10.3390/genes12101551